Fig. 1From: Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targetsComprehensive and integrated multiomics analysis of hepatocellular carcinoma (HCC). The main signaling pathways and molecular events in HCC revealed by multiomics are shown. Each mutated gene is marked with an orange font for activation, a blue font for inactivation, and a black font for unclassifiedBack to article page